News Archives - QualityStocks

TuesdayAug 18, 2026 9:45 am

Market Street Capital Inc. Leverages Expertise to Close the Financing Gap for First-of-a-Kind Energy Deals

Attracting early-stage private financing can be difficult for FOAK technologies because they require large infrastructure investments without a track record, creating a “bankability gap.” A few factors tend to separate FOAK deals that get financed from ones that stall. This is the kind of multilayer structuring problem Market Street Capital is built to help sponsors navigate, not as an energy-specific lender but as an independent advisor and structurer. Every energy technology that eventually becomes “bankable” has to survive an awkward middle stage first, the point where the tech has been proven in a lab or pilot but hasn't yet run…

TuesdayAug 18, 2026 9:00 am

SS Innovations International Inc. (NASDAQ: SSII) Record Q2 Revenue Signals Continued Momentum for SSi Mantra Robotic Surgery Platform

SS Innovations, developer of innovative surgical robotic technologies, reported record second-quarter revenue of $13.9 million, up 39.4% year over year. First-half revenue reached $25.0 million, a 65.6% increase from the same period in 2025. The company’s SSi Mantra installations rose 30.4% to 30 systems during the quarter. The installed base reached 224 SSi Mantra systems across 12 countries, with 12,272 cumulative surgeries performed. U.S. and European regulatory milestones could become important catalysts, with the company targeting FDA clearance by the first quarter of 2027 and EU CE marking by the end of 2026. The company’s telesurgery achievements are extending the…

MondayAug 17, 2026 12:30 pm

QualityStocksNewsBreaks – Surface Metals Inc. (CSE: SUR) (OTCQB: SURMF) (FSE: V6X) (WKN: A417U2) Participated in Fastmarkets Global Lithium Conference

This article has been disseminated on behalf of Surface Metals Inc. and may include paid advertising. Surface Metals (CSE: SUR) (OTCQB: SURMF) (FSE: V6X) (WKN: A417U2) participated in the Fastmarkets Global Lithium, Battery and Critical Materials Conference, held June 22-25, 2026, in Las Vegas. The conference brought together producers, developers, end users, investors, analysts and government stakeholders to discuss lithium and battery materials, supply chain developments, technological advancements and the outlook for critical minerals. Surface Metals President and CEO Steve Hanson attended the conference to engage with industry participants, investors, strategic partners and other stakeholders regarding the company lithium portfolio and…

MondayAug 17, 2026 12:00 pm

QualityStocksNewsBreaks – First Atlantic Nickel & Cobalt Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P210) Extends Alloy Max Zone With 525-Meter Mineralized Drill Hole

This article has been disseminated on behalf of First Atlantic Nickel & Cobalt Corp. and may include paid advertising. First Atlantic Nickel & Cobalt Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P210) announced that drill hole XL-26-16 at its wholly owned Pipestone XL Nickel-Cobalt Alloy Project in central Newfoundland intersected large-grain, visibly disseminated awaruite over its entire 525-meter drilled length and ended in mineralization. The hole, the deepest drilled to date at Pipestone XL, was completed approximately 445 meters south of Alloy Max discovery hole XL-26-15 and showed higher visual awaruite abundance and more frequent coarser grains. The two holes have…

FridayAug 14, 2026 10:30 am

Earth Science Tech Inc. (ETST) Seeks to Implement a Unified Strategy to Unlock True Market Value and Support Shareholders

Earth Science Tech seeks to implement a unified strategy aimed at maximizing shareholder value, resolving structural hurdles, and elevating corporate governance The company will hold a virtual annual meeting on August 31, 2026, during which shareholders will vote on key initiatives that will position ETST for an uplisting to a higher-tier exchange, eliminate the structural barriers that hinder the infusion of institutional capital, and prevent stock dilution These initiatives are informed by extensive dialogue between shareholders and management leading to a consensus that the company’s current market valuation simply does not accurately reflect its financial success or future potential The…

FridayAug 14, 2026 9:45 am

Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks

Regentis has passed 50% enrollment in the pivotal Phase III SAGE study of GelrinC, with recruitment completion targeted for the third quarter of 2026 and a PMA process expected to begin by the end of 2027. FDA approved a single-arm protocol using a historical microfracture control data package the company owns, and Regentis reports that the first 40 patients closely match that control group. In Europe, where GelrinC already holds CE Mark approval, surgeon training began in the third quarter of 2026 at Humanitas Research Hospital in Milan, supported by an expanded clinical site network and a newly approved manufacturing…

FridayAug 14, 2026 9:00 am

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Advances North American Rare Earth Portfolio as 2026 Exploration Program Builds Momentum

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals is advancing four rare earth exploration projects across Canada and the U.S. as governments seek to reduce reliance on foreign supply chains. The company has begun its 2026 field program at the Cameron REE Project in British Columbia, focusing on refining targets identified through earlier geochemical and radiometric work. Atikokan in Ontario has produced district-scale REE anomalies, while the Pinard project is entering a Phase 1 exploration program designed to generate and rank targets. The Ogden Bear Lodge project gives Powermax exposure to a…

ThursdayAug 13, 2026 9:00 am

Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds a Manufacturing and Intellectual Property Powerhouse for the Global Cartilage Repair Market

A new Japanese patent allowance follows a recent such US patent grant, strengthens protection around the organic solvent-free manufacturing process and ready-to-use liquid formulation behind GelrinC, extending the company's intellectual property footprint into one of the world's largest cartilage-repair markets. The process delivers a 5-fold increase in yield along with simplified production and commercial scalability, the manufacturing economics needed to make an off-the-shelf cartilage product commercially viable at scale. The milestone lands as Regentis advances European commercialization and passes the halfway mark in enrollment for its pivotal U.S. trial. Aging populations are pushing joint disease higher on the orthopedic agenda,…

WednesdayAug 12, 2026 9:45 am

From Tokenization to Production: MindWave Innovations Inc. (NYSE American: APUS) Positions MindChain for the Next Phase of Real-World Assets

Real-world asset activity is moving beyond proof-of-concept deployments, with tokenized funds, Treasuries, private credit and commodities increasingly being used across on-chain financial markets. As institutional participation grows, the next challenge is building secure, scalable and risk-mitigated infrastructure capable of supporting tokenized assets in production. MindWave Innovations is positioning MindChain, an insured Ethereum-compatible Layer 2, to support real-world asset applications alongside insurance, AdTech and ClimateTech through dedicated industry-specific subnetworks. For years, the promise of blockchain in financial markets centered on putting traditional assets on chain. Now, the harder question is emerging: what infrastructure is needed to make those assets useful on…

WednesdayAug 12, 2026 9:00 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Targets Disability Drivers Beyond Relapse Rates in Multiple Sclerosis

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Researchers recognize that a large share of long-term disability accumulates independent of relapses altogether, a phenomenon researchers call progression independent of relapse activity. That shift has forced researchers to look at what is actually driving PIRA. A major suspect is chronic active lesions, sometimes called smoldering or mixed active-inactive lesions. Rather than broadly suppressing the immune system, Quantum BioPharma’s Lucid-MS is designed to inhibit myelin degradation, preserve myelin and support functional recovery. Multiple sclerosis is quietly shifting how drugmakers define success. Instead of judging a therapy…

Site Search

Company Search

Category: News